2011
DOI: 10.1016/j.transci.2011.07.008
|View full text |Cite
|
Sign up to set email alerts
|

Autologous transplant in the treatment of severe aplastic anemia – A case report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
12
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 16 publications
1
12
0
Order By: Relevance
“…There is an increasing interest in evaluation of the responsibility of the CD34 + subsets for complete and longterm repopulation, as a marker of cell harvest quality 1,[10][11][12] . In our initial clinical study, as a possible and potentially more objective collection predictor, the CD34 + /CD90 + subset evaluation was also recommended 19 . Precisely, on the basis of examination of the immature SC antigens and 7-aminoactinomycin D (7-AAD) viability, we suggested that the CD34 + /CD33 -, CD34 + /CD38 -, CD34 + /DR -, CD34 + /CD90 + cells could be superior predictive factor over circulating the total CD34 + count for an optimized collection-timing and outcome of autologous SC-transplant 19 .…”
Section: Sem -Standard Error Of the Meanmentioning
confidence: 99%
See 2 more Smart Citations
“…There is an increasing interest in evaluation of the responsibility of the CD34 + subsets for complete and longterm repopulation, as a marker of cell harvest quality 1,[10][11][12] . In our initial clinical study, as a possible and potentially more objective collection predictor, the CD34 + /CD90 + subset evaluation was also recommended 19 . Precisely, on the basis of examination of the immature SC antigens and 7-aminoactinomycin D (7-AAD) viability, we suggested that the CD34 + /CD33 -, CD34 + /CD38 -, CD34 + /DR -, CD34 + /CD90 + cells could be superior predictive factor over circulating the total CD34 + count for an optimized collection-timing and outcome of autologous SC-transplant 19 .…”
Section: Sem -Standard Error Of the Meanmentioning
confidence: 99%
“…In our initial clinical study, as a possible and potentially more objective collection predictor, the CD34 + /CD90 + subset evaluation was also recommended 19 . Precisely, on the basis of examination of the immature SC antigens and 7-aminoactinomycin D (7-AAD) viability, we suggested that the CD34 + /CD33 -, CD34 + /CD38 -, CD34 + /DR -, CD34 + /CD90 + cells could be superior predictive factor over circulating the total CD34 + count for an optimized collection-timing and outcome of autologous SC-transplant 19 . Other authors also confirmed that engraftment and hematopoietic recovery are not necessarily associated with cell dose of the total CD34 + cells 10 .…”
Section: Sem -Standard Error Of the Meanmentioning
confidence: 99%
See 1 more Smart Citation
“…In practice, allogeneic transplants require both an effective conditioning regimen, as well as optimized mobilization and harvesting protocol to obtain adequate SC yield [10][11][12][13][14]. For autologous transplants, the use of an optimized cryopreservation procedure guarantees the best recovery of thawed cell [15][16][17][18][19][20][21].…”
Section: Sažetakmentioning
confidence: 99%
“…Nowadays, the typical number of apheresis required is not more than one to three, and for anticoagulation ACD-B or ACD-A (with 2.2% citrate concentration) are used [10][11][12][13][14] (Figure 2).…”
Section: Stem Cell Sources and Harvestingmentioning
confidence: 99%